Hinrich Abken

21PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemical engineering designElectrical machines and drivesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 27, 2026
Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of Gluconate.

|Feb 19, 2026
Drug-controlled CAR T cells through the regulation of cell-cell interactions.

Leo Scheller, Greta Maria Paola Giordano Attianese, Rocío Castellanos-Rueda

|Sep 13, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

Sedigheh Givi, Benedikt J Lohnes, Saber Ebrahimi

|Jun 25, 2025
Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion.

Dennis Christoph Harrer, Tim Schlierkamp-Voosen, Markus Barden

|Apr 14, 2025
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges.

Hinrich Abken

|Aug 10, 2024
Ectopic PU.1 Expression Provides Chimeric Antigen Receptor (CAR) T Cells with Innate Cell Capacities Including IFN-β Release.

Dennis Christoph Harrer, Matthias Eder, Markus Barden

Pageof 4

Frequent Collaborators

3 joint publications

Niels Schaft

3 joint publications

Jan Dörrie

2 joint publications

Clemens Franke

2 joint publications

Jens Hoffmann